Intravitreal implant corticosteroids

The following reactions have been identified during post-marketing use of OZURDEX® in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to OZURDEX® , or a combination of these factors, include: complication of device insertion ( implant misplacement), device dislocation with or without corneal edema, endophthalmitis, hypotony of the eye (associated with vitreous leakage due to injection), and retinal detachment .

Procedures undertaken by Mr Charles:
Cataract surgery (phacoemulsification and intraocular lens implantation)
Pars plana vitrectomy
Retinal detachment surgery
Macular hole surgery, without prolonged positioning
Intravitreal ocriplasmin (Jetrea) injection for VMA and small macular holes
Removal of epiretinal membranes (macular pucker)
Vitrectomy for diabetic eye disease
Intravitreal injections for diabetic macular oedema
Removal of vitreous floaters
Intravitreal injections for wet age-related macular degeneration
Anti-VEGF injections for age-related macular degeneration
Intravitreal injections for macular oedema
Management of complications of cataract surgery
Secondary lens implantation, various techniques including Artisan lens and scleral haptic fixation of lens implant
Laser capsulotomy
Laser treatment for retinal tears
Laser treatment of diabetic retinopathy
Treatment of retinal vein occlusion by laser and /or intravitreal injection
Ozurdex implants for retinal vein occlusion

Intravitreal implant corticosteroids

intravitreal implant corticosteroids


intravitreal implant corticosteroidsintravitreal implant corticosteroidsintravitreal implant corticosteroidsintravitreal implant corticosteroidsintravitreal implant corticosteroids